341 related articles for article (PubMed ID: 23418925)
41. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
Wheless JW; Almoazen H
J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
[TBL] [Abstract][Full Text] [Related]
42. [Topical rapamycin solution to treat multiple facial angiofibromas in a patient with tuberous sclerosis].
Valerón-Almazán P; Vitiello M; Abuchar A; Kerdel FA
Actas Dermosifiliogr; 2012 Mar; 103(2):165-6. PubMed ID: 21861956
[No Abstract] [Full Text] [Related]
43. Evaluation of MMP-1, MMP-10, TIMP-1, a-SMA and TGF-b1 in angiofibromas of tuberous sclerosis.
De Jesus Araújo L; Yamamoto De Almeida L; Santos Lima J; Martelli-Júnior H; Ferreti Bonan PR
Minerva Stomatol; 2011; 60(1-2):25-33. PubMed ID: 21252847
[TBL] [Abstract][Full Text] [Related]
44. [Tuberous sclerosis in childhood].
Pires CF; Anunciação GM; De Sousa WL; Santos BM; Anunciação FA; Pires AF; Pires LF
Dermatol Online J; 2008 Sep; 14(9):14. PubMed ID: 19061596
[TBL] [Abstract][Full Text] [Related]
45. Tuberous sclerosis with portal vein thrombosis, protein C and S deficiency.
Vasudevan B; Sawhney MP; Radhakrishnan S; Shilpa G
Indian J Dermatol Venereol Leprol; 2007; 73(6):412-4. PubMed ID: 18032862
[TBL] [Abstract][Full Text] [Related]
46. Genital angiofibromas in tuberous sclerosis: two cases.
Nico MM; Ito LM; Valente NY
J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
[TBL] [Abstract][Full Text] [Related]
47. Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas.
Li S; Takeuchi F; Wang JA; Fan Q; Komurasaki T; Billings EM; Pacheco-Rodriguez G; Moss J; Darling TN
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3539-44. PubMed ID: 18292222
[TBL] [Abstract][Full Text] [Related]
48. Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex.
Jóźwiak S; Kotulska K; Kasprzyk-Obara J; Domańska-Pakieła D; Tomyn-Drabik M; Roberts P; Kwiatkowski D
Pediatrics; 2006 Oct; 118(4):e1146-51. PubMed ID: 16940165
[TBL] [Abstract][Full Text] [Related]
49. Unilateral facial angiofibromas; a review of the literature.
Camprubí M; Balaguer A; Azon Masoliver A; Jiménez-Feijoo R; Escribano Subias J
Pediatr Dermatol; 2006; 23(3):303-5. PubMed ID: 16780491
[No Abstract] [Full Text] [Related]
50. [Characterisation of the paediatric population of Costa Rica with tuberous sclerosis and a description of the behaviour of the associated epilepsy].
Ulate-Campos A; Benavides-Lara A; Hernández L
Rev Neurol; 2013 Dec; 57(11):489-94. PubMed ID: 24265142
[TBL] [Abstract][Full Text] [Related]
51. Gingival enlargement as a manifestation of tuberous sclerosis: case report and periodontal management.
Korol UB; Schoor R; Nanda V; Almas K; Phelan JA
J Periodontol; 2008 Apr; 79(4):759-63. PubMed ID: 18380572
[TBL] [Abstract][Full Text] [Related]
52. Treatment of gingival fibromas using CO2 laser and electrosurgery in a patient with tuberous sclerosis.
Eisen DB; Fazel N
Dermatol Online J; 2008 Nov; 14(11):7. PubMed ID: 19094845
[TBL] [Abstract][Full Text] [Related]
53. [Eyelid and cutaneous lesions as the sole indicators of tuberous sclerosis].
Mencía-Gutiérrez E; Gutiérrez-Díaz E; Ricoy JR; Sánez-Madrazo N
Arch Soc Esp Oftalmol; 2004 Aug; 79(8):401-4. PubMed ID: 15306968
[TBL] [Abstract][Full Text] [Related]
54. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
Weiss ET; Geronemus RG
Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
[TBL] [Abstract][Full Text] [Related]
55. Giant cell angiofibroma of the eyelids: an unusual presentation of tuberous sclerosis.
Mawn LA; Jordan DR; Nerad J; Anderson R; Jabi M
Ophthalmic Surg Lasers; 1999 Apr; 30(4):320-2. PubMed ID: 10219041
[TBL] [Abstract][Full Text] [Related]
56. Rapamycin therapy for renal, brain, and skin lesions in a tuberous sclerosis patient.
Micozkadioglu H; Koc Z; Ozelsancak R; Yildiz I
Ren Fail; 2010; 32(10):1233-6. PubMed ID: 20954988
[TBL] [Abstract][Full Text] [Related]
57. Topical everolimus for facial angiofibromas in the tuberous sclerosis complex. A first case report.
Dill PE; De Bernardis G; Weber P; Lösch U
Pediatr Neurol; 2014 Jul; 51(1):109-13. PubMed ID: 24810875
[TBL] [Abstract][Full Text] [Related]
58. [Diagnosis of tuberous sclerosis complex].
Belousova ED; Dorofeeva MY; Pivovarova AM; Katusheva OV
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):89-95. PubMed ID: 26525630
[TBL] [Abstract][Full Text] [Related]
59. [Dyscromic neurocutaneous syndromes].
Sola-Casas MA; Salleras-Redonnet M
Rev Neurol; 1997 Sep; 25 Suppl 3():S259-64. PubMed ID: 9273171
[TBL] [Abstract][Full Text] [Related]
60. [Neural endoscopy in hydrocephalus treatment in a case of tuberous sclerosis].
Pyrich M; Borowiec G
Neurol Neurochir Pol; 1999; 33(1):227-34. PubMed ID: 10399739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
